Mild appetite change and early GI adaptation are common here
This inhibition preserves cellular NAD+ levels, enhancing mitochondrial function, improving fat oxidation, and supporting overall metabolic health
The honest clinical answer: it does not work like a GLP-1
The truth is much less exciting
Available in 10mg quantities, this stable gastric pentadecapeptide is engineered for laboratory environments where data integrity and compound stability are critical
What to Expect Over Time Weeks 12: Decrease in inflammation and discomfort Early improvements in digestion and gut comfort (oral form) Weeks 36: Improved tissue repair and mobility Enhanced recovery and energy levels Weeks 612+: Long-term improvements in joint, tendon, and muscle strength Sustained gut health and systemic support Results vary depending on condition, severity, and consistency of use